Original languageEnglish
Article number102418
JournalCancer treatment reviews
Volume108
DOIs
Publication statusPublished - 1 Jul 2022

    Research areas

  • Anti-HER2 treatment, Cell lines, Drug Resistance, Gastroesophageal adenocarcinoma, HER2 receptor, Xenograft

ID: 24872727